Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
All FDA-approved GLP-1 receptor agonists have been shown through clinical trials to effectively manage blood sugar levels in people newly diagnosed with type 2 diabetes
Neither includes enough participants for the medications to be submitted to the FDA for approval
Wegovy might also increase the risk of thyroid cancer, pancreatitis, gallbladder disease, kidney problems, and diabetic eye disease
Comprehensive meta-analyses of randomized controlled trials have generally not found statistically significant increases in pancreatitis risk with GLP-1 agonists compared to other diabetes treatments
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 22.82
:max_bytes(150000):strip_icc()/Wegovy-pill-pic-590ed53ed3304ba8b2388f9d78886dae.png)
US$ 20.60
US$ 21.47
![Mechanism of action of GLP-1 [25]](https://www.researchgate.net/publication/256289222/figure/fig1/AS:614177232142337@1523442671231/Mechanism-of-action-of-GLP-1-25.png)
US$ 21.27
US$ 26.33
US$ 24.76
